Phase 3 Clinical Trial to Test Opdivo in Mesothelioma Patients in United Kingdom
News
A Phase 3 British clinical trial will test whether the immune checkpoint inhibitor Opdivo (nivolumab) can help mesothelioma patients whose disease ... Read more